1,059
Participants
Start Date
February 10, 2014
Primary Completion Date
September 3, 2014
Study Completion Date
September 3, 2014
liraglutide
No treatment given.
sitagliptin
No treatment given.
Novo Nordisk Investigational Site, Malmo
Lead Sponsor
Novo Nordisk A/S
INDUSTRY